Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Status:
Withdrawn
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
Phase 1, Single-Center, Dose-Escalating, Open-Label, Safety Clinical Trial of Parenteral
Ascorbate-Meglumine as a Novel Magnetic Resonance Imaging-guided Adjunctive Therapeutic for
Stereotactic Radiosurgery (SRS).